Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Health Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About Us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Metrics

Clinical trial metrics are data points that provide insight into operational performance. They are powerful tools for assessing progress, decision-making, and measuring the strength of evidence used in clinical trials.

Clinical trial metrics are data points that provide insight into operational performance. They are powerful tools for assessing progress, decision-making, and measuring the strength of evidence used in clinical trials.

The Minimum Data Set (MDS) is a resource created to support Research Offices, Clinical Trial Units (CTUs) and other departments that run clinical trials within health settings or academic institutions. Along with the Metrics and you booklet, the table below can be used to provide clinical trial benchmarks and help to determine reporting requirements.

This project is part of a larger program of work de-mystifying the National Clinical Trials Governance Framework. A partner resource, The Implementation Workbook by Melbourne Academic Centre for Health (MACH), can also be accessed using the button below.

Access workbook

Minimum Data Set

This project is a work in progress. We'd love to hear how you're finding it. Provide your feedback

Metric
Category
Who requires the data?
Study or Site level?
Who reports the data?

Scientific Title

  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Acronym or Short Title

  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Trial registration # (ACTRN)

  • Cancer Census Data
  • Contributory or Identifier
Site
RO or CTU

Trial registration # (NCT)

  • Cancer Census Data
  • Contributory or Identifier
Site
RO or CTU

Trial registration # (Other)

  • Cancer Census Data
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Registration under Clinical Trial Notification Scheme (CTN)

  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Registration under Clinical Trial Approval Scheme (CTA)

  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Phase (Metric 1)

  • NCTGF Mandatory
  • CTU Improvement
  • Cancer Census Data
  • Teletrials / RTN Vic
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Study type

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Trial type

  • Cancer Census Data
Site
RO or CTU

Teletrial: Primary or Satellite Site

  • CTU Improvement
  • Cancer Census Data
  • Teletrials / RTN Vic
Site
RO or CTU

Teletrial format

  • Teletrials / RTN Vic
Study
RO or CTU

MMM Code

  • Teletrials / RTN Vic
Site
CTU

Overall status of trial

  • CTU Improvement
  • Cancer Census Data
Study
RO or CTU

Site status

  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
Site
RO or CTU

Common Scientific Outcome (CSO) category

  • CTU Improvement
  • Cancer Census Data
Study
CTU

Major sponsor type (Metric 1)

  • NCTGF Mandatory
  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
Site
RO or CTU

Name of sponsor

  • NCTGF Mandatory
  • CTU Improvement
Site
CTU

Type(s) of funding

  • NCTGF Mandatory
  • CTU Improvement
Study
RO or CTU

Funder(s) of trial

  • CTU Improvement
Site
CTU

Start date of the trial

  • Cancer Census Data
Study
CTU

End date of the trial

  • Cancer Census Data
Study
CTU

Completed hospitals

  • Cancer Census Data
Study
CTU

Not yet recruiting hospitals

  • Cancer Census Data
Study
CTU

Recruiting hospitals

  • CTU Improvement
  • Cancer Census Data
Study
CTU

Closed hospitals

  • Cancer Census Data
Study
CTU

Patient sex (as per trial eligibility criteria)

  • CTU Improvement
  • Cancer Census Data
Site
CTU

Clinical Trial Department

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
CTU

Date selected by trial sponsor

  • CTU Improvement
Site
CTU

Disease type

  • CTU Improvement
  • Cancer Census Data
Site
CTU

Tumour type

  • CTU Improvement
  • Cancer Census Data
Site
CTU

Total anticipated recruitment for trial (NAS metric 6)

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Study
RO or CTU

Total actual recruitment for trial (NAS Metric 6)

  • NCTGF Mandatory
  • NCTGF Suggested
Study
RO or CTU

Anticipated recruitment at site (NAS Metric 7)

  • NCTGF Mandatory
  • CTU Improvement
  • Teletrials / RTN Vic
  • NCTGF Suggested
Site
RO or CTU

Actual recruitment at site (NAS metric 7)

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

Total NEW participants YYYY

  • NCTGF Mandatory
  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
Site
RO or CTU

Number of potential participants screened at site (Screen Failures)

  • CTU Improvement
  • NCTGF Suggested
Site
CTU

Total FOLLOW UP patients

  • CTU Improvement
  • Cancer Census Data
Site
CTU

Time to First Patient First Visit (FPFV)

  • CTU Improvement
  • NCTGF Suggested
Site
CTU

Site Initiation Visit

  • CTU Improvement
  • Teletrials / RTN Vic
Site
CTU

Year of birth for each NEW participant

  • CTU Improvement
  • Cancer Census Data
  • Teletrials / RTN Vic
Site
CTU

Residental postcode for each NEW participant

  • CTU Improvement
  • Cancer Census Data
  • Teletrials / RTN Vic
Site
CTU

Aboriginal/Torres Strait Islander and First Nations

  • NCTGF Mandatory
  • CTU Improvement
Site
CTU

Culturally and Linguistically Diverse (CALD)

  • CTU Improvement
Site
CTU

Mode of HREC review

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Low risk

  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

Reviewing HREC state

  • NCTGF Suggested
Site
RO or CTU

Reviewing HREC

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

HREC meeting date

  • NCTGF Suggested
Site
RO or CTU

HREC submission date

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Study
RO or CTU

HREC validation date

  • NCTGF Suggested
  • Contributory or Identifier
Study
RO or CTU

HREC approval date

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

HREC reference number

  • CTU Improvement
  • Cancer Census Data
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

SSA reference number

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

SSA submssion date

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

SSA validation date

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

SSA authorisation date

  • CTU Improvement
  • NCTGF Suggested
  • Contributory or Identifier
Site
RO or CTU

Derived metrics

Overall Study Start-Up Timeline (Regulatory Timeline) – Without Clock (NAS Metric 2)

  • NCTGF Mandatory
  • CTU Improvement
Study
RO or CTU

HREC and SSA/Site Assessment Approval Timeline – With Clock (NAS Metric 3)

  • NCTGF Mandatory
  • CTU Improvement
Study and site
RO or CTU

HREC Approval Timeline Without Clock (NAS Metric 4a)

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Study
RO or CTU

HREC Approval Timeline With Clock (NAS Metric 4b)

  • NCTGF Mandatory
  • NCTGF Suggested
Study
RO or CTU

SSA/Site Authorisation Timeline - Without Clock (5a) From HREC Approval Date/SSA Validation Date (NAS - Metric 5)

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

SSA/Site Authorisation Timeline - With Clock (5b) From HREC Approval Date/SSA Validation Date (NAS Metric 5)

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

Number of trials pending site authorisation by reporting period and /or year to date

  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

FTE on trial

  • NCTGF Mandatory
  • CTU Improvement
  • NCTGF Suggested
Site
CTU

Trials cost

  • CTU Improvement
  • NCTGF Suggested
Site
CTU

Total Inbound (internal and external) Investment Annually (FY)
Actual/Planned (NAS Metric 8)

  • NCTGF Mandatory
  • CTU Improvement
Site
RO or CTU

Clinical Incidents

  • CTU Improvement
  • NCTGF Suggested
Site
RO or CTU

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.